Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Tilray Inc    TLRY

TILRAY INC (TLRY)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/12/2018 11/13/2018 11/14/2018 11/15/2018 11/16/2018 Date
113.44(c) 111.55(c) 102.34(c) 107.27(c) 110.71 Last
2 902 048 2 362 056 2 841 306 2 438 643 1 056 829 Volume
+4.08% -1.67% -8.26% +4.82% +3.21% Change
More quotes
Company
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids.Its products include dried cannabis and cannabis extracts.The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada. 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on TILRAY INC
11/14TILRAY : Management's Discussion and Analysis of Financial Condition and Results..
AQ
11/14INTELGENX TECHNOLOGIES : Closes Private Placement Financing
AQ
11/13TILRAY : Cannabis firm Tilray shares pull back on bigger-than-expected loss
RE
11/13TILRAY : B.C.-based pot producer Tilray reports revenue surge, net loss
AQ
11/13TILRAY, INC. : Results of Operations and Financial Condition, Financial Statemen..
AQ
11/08INTELGENX TECHNOLOGIES : Announces Definitive Agreement with Tilray to Form an E..
AQ
11/07Cannabis shares light up as U.S. voter support for industry grows
RE
11/07Michigan vote to legalize pot fires up investor momentum behind cannabis
RE
10/26High as a kite? Danish cannabis firm StenoCare shares surge on debut
RE
10/26High as a kite? Danish cannabis firm StenoCare shares surge on debut
RE
More news
Sector news : Pharmaceuticals - NEC
08:31aASTRAZENECA : Imfinzi Cancer-Drug Trial Misses the Mark
DJ
08:15aSHIRE : Rule 2.9 Announcement
DJ
02:15aJOHNSON & JOHNSON : New jury fails to reach verdict in J&J South Carolina talc c..
RE
12:46aBAYER : California judge orders next Monsanto weed-killer cancer trial for March
RE
11/15British stocks battered on Brexit deal backlash, exporters gain
RE
More sector news : Pharmaceuticals - NEC
Latest Tweets
02:05aGold nears one-week high on Technical Safe Haven Buying $GC_F $SI_F $HG_F..
3
12:15aWhat Is CBD — And How Can Investors Take Advantage Of It?  
11/15$RETC MANIPULATION is pathetic. Waited till 4pm to sell 20k? $TOPS $OHGI $SH..
2
11/15$ACB $CGC $TLRY $TGODF
2
11/15$TLRY - for the record, all 6 blocks executed simutaneously. 
More tweets
Qtime:73
News from SeekingAlpha
11/15A MARIJUANA TRADE : Green Organic Dutchman Could Soon Produce 156,000 Kilograms .. 
11/15The Canadian Cannabis Domination Story Is A Myth 
11/15Tilray Losses Continue To Soar 
11/14Tilray (TLRY) Presents At Morgan Stanley Global Consumer And Retail Conferenc.. 
11/14TILRAY : Disaster Waiting To Happen 
Chart TILRAY INC
Duration : Period :
Tilray Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TILRAY INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Managers
NameTitle
Brendan Kennedy President, Chief Executive Officer & Director
Mark Castaneda Chief Financial Officer, Secretary & Treasurer
Joshua Eades Chief Science Officer & Vice President
Christine Thompson St. Clare Independent Director
Maryscott Greenwood Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TILRAY INC0.00%9 992
JOHNSON & JOHNSON3.24%386 875
PFIZER18.47%248 878
NOVARTIS6.63%222 584
ROCHE HOLDING LTD.0.93%213 164
MERCK AND COMPANY31.67%192 662